- Home
- AMRX vs PTEN Comparison
AMRX vs PTEN Comparison
Compare AMRX & PTEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRX
- PTEN
- Stock Information
- Founded
- AMRX 2002
- PTEN 1978
- Country
- AMRX United States
- PTEN United States
- Employees
- AMRX N/A
- PTEN N/A
- Industry
- AMRX Biotechnology: Pharmaceutical Preparations
- PTEN Oil & Gas Production
- Sector
- AMRX Health Care
- PTEN Energy
- Exchange
- AMRX Nasdaq
- PTEN Nasdaq
- Market Cap
- AMRX 2.5B
- PTEN 2.3B
- IPO Year
- AMRX N/A
- PTEN 1993
- Fundamental
- Price
- AMRX $8.23
- PTEN $6.18
- Analyst Decision
- AMRX Strong Buy
- PTEN Buy
- Analyst Count
- AMRX 4
- PTEN 13
- Target Price
- AMRX $11.50
- PTEN $9.85
- AVG Volume (30 Days)
- AMRX 1.9M
- PTEN 12.9M
- Earning Date
- AMRX 08-08-2025
- PTEN 07-23-2025
- Dividend Yield
- AMRX N/A
- PTEN 5.24%
- EPS Growth
- AMRX N/A
- PTEN N/A
- EPS
- AMRX N/A
- PTEN N/A
- Revenue
- AMRX $2,830,186,000.00
- PTEN $5,148,088,000.00
- Revenue This Year
- AMRX $9.84
- PTEN N/A
- Revenue Next Year
- AMRX $7.33
- PTEN N/A
- P/E Ratio
- AMRX N/A
- PTEN N/A
- Revenue Growth
- AMRX 13.42
- PTEN 5.82
- 52 Week Low
- AMRX $6.32
- PTEN $5.12
- 52 Week High
- AMRX $9.48
- PTEN $11.27
- Technical
- Relative Strength Index (RSI)
- AMRX 61.71
- PTEN 43.86
- Support Level
- AMRX $8.05
- PTEN $5.67
- Resistance Level
- AMRX $8.24
- PTEN $6.06
- Average True Range (ATR)
- AMRX 0.21
- PTEN 0.26
- MACD
- AMRX 0.03
- PTEN -0.04
- Stochastic Oscillator
- AMRX 90.91
- PTEN 13.81
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
About PTEN Patterson-UTI Energy Inc.
Patterson-UTI Energy Inc is one of the substantial land rig drilling contractors in the United States. Its 2023 merger with NexTier greatly expanded its pressure pumping operations, as well, and the firm now controls nearly 20% of the North American market for drilling and completions services. The company operates under three reportable business segments: (i) drilling services, (ii) completion services, and (iii) drilling products. It also provides directional drilling services and tool rental services in united states onshore oil and gas basins.